NCT02166346: Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch) |
|
|
| Completed | 2 | 24 | US | Dalfampridine, Ampyra, Placebo, Sugar pill | Johns Hopkins University, Acorda Therapeutics | Transverse Myelitis, Neuromyelitis Optica, Idiopathic Transverse Myelitis, Myelitis NOS | 01/17 | 01/17 | | |
